Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Immunic, Inc.
13G
IMUX · 4525EP200
|
6.1% |
8/4/2026
Event 6/30/2026
|
|||
| Laurion Capital Management LP | 6.1% | ||||
| Benjamin Alexander Smith | 6.1% | ||||
| Janaka Sheehan Maduraperuma | 6.1% | ||||
|
Rallybio Corp
13G/A
Amendment 1
RLYB · 75120L209
|
0% |
8/4/2026
Event 6/30/2026
|
|||
| Laurion Capital Management LP | 0% | ||||
| Benjamin Alexander Smith | 0% | ||||
| Janaka Sheehan Maduraperuma | 0% | ||||
|
Rallybio Corp
13G
RLYB · 75120L209
|
5.7% |
4/29/2026
Event 3/31/2026
|
|||
| Laurion Capital Management LP | 5.7% | ||||
| Benjamin Alexander Smith | 5.7% | ||||
| Janaka Sheehan Maduraperuma | 5.7% | ||||
|
Pyxis Oncology, Inc.
13G/A
Amendment 2
PYXS · 747324101
|
7.7% |
2/9/2026
Event 12/31/2025
|
|||
| Laurion Capital Management LP | 7.7% | ||||
| Benjamin Alexander Smith | 7.7% | ||||
| Janaka Sheehan Maduraperuma | 7.7% | ||||